Chris Boshoff, MD, PhD, FMedSci - Pfizer | LinkedIn (original) (raw)

Articles by Chris

Reimagining the Future of Cancer Care, Together

Today is a great day for Pfizer, and, more importantly, for people living with cancer, as we have announced the…

Science Will Win Against Multiple Myeloma

Nearly 200 years after multiple myeloma (MM), an aggressive blood cancer that affects plasma cells made in the bone…

Peeking into 2023 for Oncology & Rare Diseases

As we kick off 2023, I’m looking forward to a busy year of scientific innovation. Advances in cell therapy, gene…

Joining Forces for Better Blood Disorder Treatment

I am #PfizerProud to be joining scientists from around the world as we gather in New Orleans for this year’s American…

Harnessing Oncology’s “Golden Age” of Research for a Better Tomorrow

Every two seconds, someone in the world is diagnosed with cancer.[1] This devastating and far-reaching disease affects…

Our Relentless Pursuit Against Treatment-Resistant Cancer

On the eve of the European Society for Medical Oncology Virtual Congress 2020 (ESMO), I am struck by the words of…

Oncology Research Must Continue to Forge Ahead Amidst COVID-19

We are all bombarded daily by a deluge of information regarding COVID-19 and its devastating global impact. Within six…

Reimagining Traditional Oncology Clinical Trials with Real-World Data

As reported by The Financial Times this weekend, the power of data to accelerate drug discovery and research represents…

Activity

Experience & Education

More activity by Chris

Explore collaborative articles

We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.

Explore More